section name header

Evidence summaries

Meditation Therapy for Anxiety Disorders

The evidence is insufficient for conclusions on the effectiveness of meditation therapy for anxiety disorders. Level of evidence: "D"

A Cochrane review [Abstract] 1 included 2 studies with a total of 76 subjects. Both studies, duration ranging from 12 to 18 weeks, were of moderate quality and used active control comparisons (another type of meditation, relaxation, biofeedback). Anti-anxiety drugs were used as standard treatment. In one study transcendental meditation showed a reduction in anxiety symptoms and electromyography score comparable with electromyography-biofeedback and relaxation therapy. Another study compared Kundalini Yoga (KY), with Relaxation/Mindfulness Meditation. The Yale-Brown Obsessive Compulsive Scale showed no statistically significant difference between groups. The overall dropout rate in both studies was high (33-44%). Neither study reported on adverse effects of meditation.

Comment: The quality of evidence is downgraded by limitations in study quality (inadequate standardisation of interventions, high drop-out rates), by imprecise results (few patients and wide confidence intervals), by inconsistency (heterogeneity in interventions and outcomes) and by indirectness (differences in studied interventions).

References

  • Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev 2006 Jan 25;(1):CD004998. [PubMed]

Primary/Secondary Keywords